BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ataga KI, Saraf SL, Derebail VK. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol 2022;18:361-77. [PMID: 35190716 DOI: 10.1038/s41581-022-00540-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wonkam A. The future of sickle cell disease therapeutics rests in genomics. Dis Model Mech 2023;16. [PMID: 36815490 DOI: 10.1242/dmm.049765] [Reference Citation Analysis]
2 Lebensburger JD, Derebail VK. Sickle Cell Disease and the Kidney. Hematology/Oncology Clinics of North America 2022;36:1239-1254. [DOI: 10.1016/j.hoc.2022.08.009] [Reference Citation Analysis]
3 Afangbedji N, Jerebtsova M. Glomerular filtration rate abnormalities in sickle cell disease. Front Med 2022;9:1029224. [DOI: 10.3389/fmed.2022.1029224] [Reference Citation Analysis]
4 Penkert RR, Azul M, Sealy RE, Jones BG, Dowdy J, Hayden RT, Tang L, Ross AC, Hankins JS, Hurwitz JL. Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19. Nutrients 2022;14:3415. [PMID: 36014920 DOI: 10.3390/nu14163415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ren G, Setty S, Zhang X, Susma A, Ruiz MAD, Minshall RD, Lash JP, Gordeuk VR, Saraf SL. Improvement of Hemolytic Anemia with GBT1118 is Reno-protective in Transgenic Sickle Mice. Blood Adv 2022:bloodadvances. [PMID: 35759756 DOI: 10.1182/bloodadvances.2022007809] [Reference Citation Analysis]